Diabetes & CV Disease
Sort by:
University of Colorado Department of Medicine
Intermittent Energy Restriction for Obesity Treatment
FEATURING
Victoria Catenacci
- 560 views
- May 16, 2024
- 2
Baystate Health
Ozempic, Zepbound, and More: Behavioral Interventions & Weight Loss Medications For Heart Health
FEATURING
Michele Gortakowski,
Kathryn Jobbins
- 841 views
- May 22, 2024
- 11
Frank Lavernia
Diabetes Care in an Underserved Population Clinic: A Case Study Discussion
FEATURING
Carrie O'Day
- 304 views
- May 22, 2024
- 5
Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "Office-Based Removal of Small Residual Kidney Stone Fragments Reduces Relapse Rates"
FEATURING
Mathew Sorensen
- 1,122 views
- May 23, 2024
- 3
Stanford Medicine
What You Need to Know About The New Obesity Medications
FEATURING
Aaron Yeoh
- 1,377 views
- June 1, 2024
- 15
Lilly Diabetes
A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Medication
FEATURING
Barbara Hirsch
- 2,177 views
- June 4, 2024
- 9
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two Incretin Medications for T2D
FEATURING
S. Christopher Shadid
- 1,965 views
- June 4, 2024
- 5
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two T2D Medications
FEATURING
Barbara Hirsch
- 1,979 views
- June 4, 2024
- 2
Right Care Initiative
Epidemiology of Cardiovascular Disease, Diabetes, and Metabolic Syndrome in South Asians
FEATURING
Latha Palaniappan
- 3 views
- June 4, 2024
Right Care Initiative
The ABCs of Risk Evaluation for Coronary Artery Disease and Diabetes Mellitus in South Asians
FEATURING
Cesar Molina
- 13 views
- June 4, 2024
HeartFlow
The importance of lesion-specific FFRCT values in the non-invasive assessment of coronary artery disease
- 1,107 views
- June 4, 2024
- 11
Baylor College of Medicine
Anesthesia and GLP-1R Agonists
FEATURING
Wasif M. Abidi
- 746 views
- June 4, 2024
- 8
Cedars Sinai
Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity
FEATURING
Martha Gulati
- 990 views
- June 4, 2024
- 10
Cedars Sinai
Post-Debate Q&A: Should GLP-RA be First Line Therapy for Treatment of Obesity?
FEATURING
Kulmeet Sandhu,
Martha Gulati
- 122 views
- June 4, 2024
Cedars Sinai
Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity...NOT
FEATURING
Kulmeet Sandhu
- 1,519 views
- June 4, 2024
- 6
Omnipod®
Automated Insulin Delivery Systems: The Omnipod 5 - TCOYD
FEATURING
Steven Edelman,
Jeremy Pettus
- 107 views
- June 5, 2024
ARCH Advanced Revascularization Symposium
Heart Failure: Contemporary Therapeutic Paradigm
FEATURING
Amanda Verma
- 175 views
- June 6, 2024
- 1
Omnipod®
The Omnipod 5 Algorithm: How it Works - TCOYD
FEATURING
Steven Edelman,
Jeremy Pettus
- 131 views
- June 6, 2024
- 1
Omnipod®
Optimizing Omnipod 5 Therapy: Case Studies - TCOYD
FEATURING
Steven Edelman,
Jeremy Pettus
- 110 views
- June 7, 2024
Scripps Health
Guideline Directed Medical Therapy for Heart Failure with Reduced EF
FEATURING
Thomas Heywood
- 630 views
- June 10, 2024
- 2
Ploutarchos Tzoulis
Predictors of Poor Response to Semaglutide for Weight Management
- 3,232 views
- June 10, 2024
- 21
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments - 2024 Update
FEATURING
Rajeev C. Mohan
- 234 views
- June 11, 2024
- 1